Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4261 AL 4275

CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease

Zhang Z, Gan Q, Han J, Tao Q, Qiu WQ, Madri JA.

J Cereb Blood Flow Metab. 2023 Jul;43(7):1027-1041. doi: 10.1177/0271678X231170041. Epub 2023 Apr 12.

Bioinformatic analysis of the SPs and NFTs proteomes unravel putative biomarker candidates for Alzheimer's disease

Ferreira MJC, Soares Martins T, Alves SR, Rosa IM, Vogelgsang J, Hansen N, Wiltfang J, da Cruz E Silva OAB, Vitorino R, Henriques AG.

Proteomics. 2023 Aug;23(15):e2200515. doi: 10.1002/pmic.202200515. Epub 2023 May 1.

Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer's disease biomarkers

van Zalm PW, Ahmed S, Fatou B, Schreiber R, Barnaby O, Boxer A, Zetterberg H, Steen JA, Steen H.

Cell Rep Med. 2023 Apr 18;4(4):101005. doi: 10.1016/j.xcrm.2023.101005.

Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum

Kuhn E, Perrotin A, La Joie R, Touron E, Dautricourt S, Vanhoutte M, Vivien D, de La Sayette V, Chételat G; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2023 Jun 13;100(24):e2454-e2465. doi: 10.1212/WNL.0000000000207338. Epub 2023 Apr 21.

Methodological flaws in"diagnostic accuracy of blood biomarkers for Alzheimer's disease and amnestic mild cognitive impairment: A meta-analysis"

Hsu YP, Hsu CW, Chen LF, Liu YK.

Ageing Res Rev. 2023 Jul;88:101938. doi: 10.1016/j.arr.2023.101938. Epub 2023 Apr 23.

Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy

Liew Y, Retinasamy T, Arulsamy A, Ali I, Jones NC, O'Brien TJ, Shaikh MF.

J Alzheimers Dis. 2023;94(s1):S253-S265. doi: 10.3233/JAD-230059.

Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis

Donaghy PC, Carrarini C, Ferreira D, Habich A, Aarsland D, Babiloni C, Bayram E, Kane JP, Lewis SJ, Pilotto A, Thomas AJ, Bonanni L; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment Lewy Body Dementias Prodromal Working Group.

Alzheimers Dement. 2023 Jul;19(7):3186-3202. doi: 10.1002/alz.13105. Epub 2023 Apr 24.

Young Onset Alzheimer's Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association

Vinceti G, Gallingani C, Zucchi E, Martinelli I, Gianferrari G, Simonini C, Bedin R, Chiari A, Zamboni G, Mandrioli J.

Genes (Basel). 2023 Apr 17;14(4):930. doi: 10.3390/genes14040930.

Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays

Hsiao WW, Angela S, Le TN, Ku CC, Hu PS, Chiang WH.

J Alzheimers Dis. 2023;93(3):821-845. doi: 10.3233/JAD-221202.

Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease

Lambert JC, Ramirez A, Grenier-Boley B, Bellenguez C.

Mol Psychiatry. 2023 Jul;28(7):2716-2727. doi: 10.1038/s41380-023-02076-1. Epub 2023 May 2.

Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease

Xu Y, Jiang H, Zhu B, Cao M, Feng T, Sun Z, Du G, Zhao Z.

CNS Neurosci Ther. 2023 Aug;29(8):2060-2073. doi: 10.1111/cns.14238. Epub 2023 May 5.

Amyloid PET: A Potential Biomarker for Individuals with Mild Traumatic Brain Injury

Haller S.

Radiology. 2023 Jun;307(5):e230671. doi: 10.1148/radiol.230671. Epub 2023 May 9.

Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta-analysis

García-García I, Fernández-Andújar M, Narváez M, García-Casares N.

Obes Rev. 2023 Aug;24(8):e13573. doi: 10.1111/obr.13573. Epub 2023 May 10.

GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim KY, Shin KY, Chang KA.

Cells. 2023 May 4;12(9):1309. doi: 10.3390/cells12091309.

Revolutionizing the Early Detection of Alzheimer's Disease through Non-Invasive Biomarkers: The Role of Artificial Intelligence and Deep Learning

Vrahatis AG, Skolariki K, Krokidis MG, Lazaros K, Exarchos TP, Vlamos P.

Sensors (Basel). 2023 Apr 22;23(9):4184. doi: 10.3390/s23094184.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias